LB6A.F - Isodiol International Inc.

Frankfurt - Frankfurt Delayed Price. Currency in EUR
0.258
+0.022 (+9.32%)
At close: 12:37PM CEST
Stock chart is not supported by your current browser
Previous Close0.236
Open0.235
Bid0.233 x 1100000
Ask0.251 x 1000000
Day's Range0.235 - 0.260
52 Week Range0.223 - 0.656
Volume5,700
Avg. Volume7,938
Market Cap100.121M
BetaN/A
PE Ratio (TTM)N/A
EPS (TTM)-0.021
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire22 days ago

    Isodiol International Inc. Outlines Strategy for Balanced, Long-Term Growth to Increase Shareholder Value

    “Over the past 6 months, we made significant investments that built a diverse foundation for the Company through acquisitions, and we are now shifting our focus to optimally operating our various business segments.  Specifically, we are leveraging these recent acquisitions to scale up and maximize the growth of the Company, while taking advantage of developing opportunities that are arising from positive changes in regulations that affect hemp and CBD around the globe,” said the Company’s CEO, Marcos Agramont. To give effect to these initiatives, the Company is sharpening its focus on three core business strategies designed to increase shareholder value through primary Business to Business (B2B) revenues and secondary retail revenues.

  • GlobeNewswire24 days ago

    Isodiol International Inc. Applauds the FDA’s Decision to Recognize the Medical Benefits of CBD at Higher Concentrations and Announces Corporate Restructure

    VANCOUVER, British Columbia, June 27, 2018-- Isodiol International Inc., a global CBD innovator specializing in hemp-based health and wellness products, the development of pharmaceutical CBD delivery methods ...

  • GlobeNewswirelast month

    Isodiol International Inc. Announces Binding Agreement to Acquire 51% of Round Mountain Technologies, LLC and Commences Certified Organic Hemp Farming in Nevada

    Isodiol International Inc. (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global CBD innovator specializing in hemp based health and wellness products, the development of pharmaceutical CBD delivery methods and the manufacturing of a pure, natural CBD as an Active Pharmaceutical Ingredient (API) for use in finished pharmaceutical products (FPPs), is pleased to announce that it has entered into a binding agreement to acquire 51% of Round Mountain Technologies, LLC (“RMT”), a cultivator of organic hemp with operations in Nevada. RMT holds a license from the State of Nevada to cultivate organic hemp in Nye County.  The property consists of approximately 155 acres, of which RMT and Isodiol intend to plant 70 acres within the coming weeks, initially.  RMT and Isodiol will contribute to Nevada’s local economy by ensuring that all hemp harvested by RMT will be processed within the State of Nevada.

  • GlobeNewswirelast month

    Isodiol International, Inc. Announces May 2018 Revenues and Corporate Update

    Isodiol International Inc. (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global CBD innovator specializing in hemp based health and wellness products, the development of pharmaceutical CBD delivery methods and the manufacturing of a pure, natural CBD as an Active Pharmaceutical Ingredient (API) for use in finished pharmaceutical products (FPPs), announces unaudited May 2018 consolidated revenue numbers of $3,316,646 CDN. Marcos Agramont, CEO of Isodiol, stated, “May was a historic month for revenues. The company has officially opened its new Corporate Headquarters at 2710 – 200 Granville St., Vancouver, BC V6C 1S4.

  • GlobeNewswire2 months ago

    Isodiol International Inc. Announces KURE Corp Expansion Plans

    Isodiol International Inc. (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global CBD innovator specializing in the development of pharmaceutical and health and wellness products and now supporting the pharmaceutical industry at large with its recently approved CBD as an Active Pharmaceutical Ingredient, announces that its wholly owned subsidiary, KURE Corp (“KURE”), has finalized plans for the expansion of its national retail footprint. KURE plans to expand by opening several brick and mortar locations, acquiring existing vapor stores and introducing their new KURE Vape Pod™ concept in cities across the US and Canada.

  • GlobeNewswire2 months ago

    Isodiol International Inc. Completes Acquisition of Farmtiva Inc. for 51% Ownership and Completes First Planting of Farm Bill Compliant Hemp in California

    Isodiol believes the partnership between the Imperial Valley Conservation Research Center and Farmtiva will harvest the first legally grown hemp in California in 24 years with authorization pursuant to the Agricultural Act of 2014 § 7606 (“2014 Farm Bill”). VANCOUVER, British Columbia, June 04, 2018 (GLOBE NEWSWIRE) -- Isodiol International Inc. (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global CBD innovator specializing in the development of pharmaceutical and health and wellness products and now supporting the pharmaceutical industry at large with its recently approved CBD as an Active Pharmaceutical Ingredient, announces that it has closed its acquisition of a 51% equity stake in Farmtiva Inc. (“Farmtiva”), a cultivator of hemp that also provides hemp farming and distribution support for farmers and other industry participants.

  • GlobeNewswire2 months ago

    Isodiol International Inc. Announces Closing of Strategic Non-Brokered Offering for Total Proceeds of $18 Million

    “We are extremely pleased to close this strategic investment,” said CEO of Isodiol, Marcos Agramont.  “With this additional funding, the Company is now well positioned to further execute its plan of aggressive global expansion and also continue to be a global CBD innovator. Isodiol International Inc. is the market leader in pharmaceutical grade phytochemical compounds and the industry leader in the manufacturing and development of CBD consumer products.

  • GlobeNewswire2 months ago

    Isodiol International Inc. Announces Letter of Intent to Supply 99.5%+ Cannabidiol Isolate to Sundial

    Isodiol International Inc. (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global CBD innovator specializing in the development of pharmaceutical and health and wellness products and now supporting the pharmaceutical industry at large with its recently approved CBD as an Active Pharmaceutical Ingredient, is pleased to announce that it has signed a Letter of Intent (“LOI”) with Sundial Growers Inc. (“Sundial ”), a privately held Alberta-based Health Canada ACMPR-approved licensed producer of medical cannabis, to import CBD isolate into Canada, subject to applicable regulatory approvals.

  • Business Wire2 months ago

    Isodiol International Inc. Announces Letter of Intent to Supply 99.5%+ Pharma-Grade Cannabidiol to Zenabis

    Isodiol International Inc. (ISOL.CN) (ISOLF) (FSE:LB6A.F) (the “Company” or “Isodiol”), a global innovator specializing in the development of pharmaceutical and wellness products, is pleased to announce that it has signed a Letter of Intent (“LOI”) with Zenabis Ltd. (“Zenabis ”), one of Canada’s largest Licensed Producers, to import CBD isolate as an Active Pharmaceutical Ingredient, into Canada from Isodiol’s GMP-certified production facility in the United Kingdom. Zenabis is a Canadian biopharmaceutical company positioned to become one of the largest cannabis producers in Canada, with facilities totalling more than 400,000 square feet of cannabis production space. Marcos Agramont, CEO of Isodiol, stated: “Isodiol is pleased to announce another supply agreement for its highest quality, pharma grade CBD isolate.

  • GlobeNewswire3 months ago

    Isodiol International Inc. Increases Size of Non-Brokered Offering and Retains Clarus Securities as Financial Advisor

    Isodiol International Inc. (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global CBD innovator specializing in the development of pharmaceutical, health, and wellness products and now supporting the pharmaceutical industry at large with its recently approved CBD as an Active Pharmaceutical Ingredient, is pleased to announce that it will be increasing the size of its previously announced private placement from $10,000,000 to $18,000,000 (the “Private Placement” or the “Offering”).  The Company has also engaged Clarus Securities Inc. as financial advisor in connection with the Offering.

  • GlobeNewswire3 months ago

    Isodiol International Inc. Announces Letter of Intent to Supply 99.5%+ Pharma-Grade Cannabidiol to Zenabis

    Zenabis is a Canadian biopharmaceutical company positioned to become one of the largest cannabis producers in Canada, with facilities totalling more than 400,000 square feet of cannabis production space. Zenabis intends to import a minimum of 3,000 g of such CBD isolate per month for the purposes of R&D and new product formulation.

  • GlobeNewswire3 months ago

    Isodiol International Inc. Announces Binding Agreement to Acquire 51% of Farmtiva and Commence Hemp Farming in California

    Farmtiva has an exclusive partnership agreement with the not-for-profit group, Imperial Valley Conservation Research Center (“IVCRC”), and together they anticipate planting the first California hemp crop within the next three weeks. This project will be a first in California for hemp legally grown under the Agricultural Act of 2014 § 7606 (“2014 Farm Bill”) in California.  As an "established agricultural research institution," under Food and Agricultural Code (FAC) Section 81000, the project is exempt from registration and may currently grow industrial hemp in California.

  • GlobeNewswire3 months ago

    Isodiol International Inc. Completes Acquisition of KURE™ Corp

    Isodiol International Inc. (CSE: ISOL) (OTC:ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global CBD innovator specializing in the development of pharmaceutical and wellness products, is pleased to announce that the Company has completed the merger acquisition of 100% of KURE™ Corp. a leading specialty vape retailer headquartered in Charlotte, North Carolina, with retail locations throughout the United States. KURE specializes in the retailing of vaporizers and e-cigarettes, e-juices, and related accessories (kurevapes.com, kuresociety.com). By elevating the environment and customer experience, KURE has paved a completely new path to the rapidly growing vaping and e-cigarette industry and operates e-juice bars and lounges with plans for rapid domestic and international expansion.

  • GlobeNewswire3 months ago

    Isodiol Receives Government Approval for Pure, Natural CBD as an Active Pharmaceutical Ingredient

    MHRA is an executive agency of the United Kingdom’s Department of Health and is the regulatory agency that regulates medicines and medical devices. The MHRA is also a part of the European system of approval, where the MHRA or other national bodies can take on the verification work on behalf of all its members.  Further, the MHRA is recognised globally as an authority in its field and plays a leading role in protecting and improving public health and supports innovation through scientific research and development.

  • GlobeNewswire3 months ago

    Isodiol International Inc. Announces the Launch of 3 New Cannabidiol (CBD) Product Categories with Level Brands Inc.

    VANCOUVER, British Columbia, April 24, 2018-- Isodiol International Inc., a global Bioactive CBD innovator specializing in the development of pharmaceutical and wellness products, and Level Brands Inc., ...